A study from the University of California San Diego introduces “reverse metabolomics,” a method combining organic synthesis, data science, and mass spectrometry. The study leverages public metabolomics data, making groundbreaking discoveries about human molecules and their roles in diseases like inflammatory bowel disease (IBD). The researchers suggest potential therapeutic applications, such as pills containing microbes or drugs targeting these newly identified molecules. This work, part of a precision nutrition initiative, holds promise for both diagnosing and treating IBD.
Reference: Mlynaryk N. Reverse Metabolomics: New Method Finds Biomarker for Inflammatory Bowel Disease. UC San Diego Today. Published December 05, 2023. Accessed December 15, 2023. https://today.ucsd.edu/story/reverse-metabolomics-new-method-finds-biomarker-for-inflammatory-bowel-disease
